DIAMOX
ACETAZOLAMIDE
Approval overview DIAMOX is listed in Drugs@FDA under application 008943 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAZOLAMIDE Form and strength TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2025-10-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview DIAMOX is listed in Drugs@FDA under application 008943 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAZOLAMIDE Form and strength TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2025-10-01 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.